Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of bOPV Schedules in Chinese Infants
NCT02785705Phase 3Completed
- Start
- Apr 2015
- Primary completion
- Aug 2015
- Modality
- Live Attenuated Vaccines
01
Overview
Phase 3, randomised, open-label trial of bivalent oral poliovirus vaccine in poliomyelitis (6 arms). Primary endpoint: Proportion of infants with seroconversion. Started Apr 2015; status: completed.
02
Drugs
bivalent oral poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT02785705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02785705.